Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,967,527
Closed -$19.3M 77
2025
Q2
$19.3M Hold
1,967,527
0.28% 50
2025
Q1
$14.3M Sell
1,967,527
-5,510,534
-74% -$48.2M 0.22% 53
2024
Q4
$58.5M Buy
7,478,061
+99,513
+1% +$819K 0.88% 32
2024
Q3
$54.6M Hold
7,378,548
0.79% 32
2024
Q2
$59.1M Hold
7,378,548
0.92% 32
2024
Q1
$85.9M Buy
7,378,548
+1,799,617
+32% +$19.9M 1.27% 29
2023
Q4
$62.3M Buy
+5,578,931
New +$51.3M 0.97% 29

Other funds holding ETNB

RTW Investments's ETNB Position: Q3 2025 in Review

RTW Investments sold out of 89bio (ETNB) in Q3 2025, closing a stake of 1,967,527 shares — an estimated $19.3M sold.

RTW Investments first reported a position in ETNB in Q4 2023 and held it in 7 quarters. The position peaked at $85.9M in Q1 2024. 198 funds tracked by Wall St. Rank hold ETNB as of Q3 2025.

  • RTW Investments reported no remaining 89bio position as of Q3 2025 after selling out during the quarter.
  • RTW Investments sold 1,967,527 89bio shares in Q3 2025, an estimated $19.3M.
  • RTW Investments first reported a position in 89bio in Q4 2023 and held it in 7 quarters.
  • RTW Investments's 89bio position peaked at $85.9M in Q1 2024.
  • 198 funds tracked by Wall St. Rank held 89bio as of Q3 2025.

Based on RTW Investments's 13F filing for Q3 2025, filed 14 Nov 2025.